| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,310,000,000 |
| Market
Cap: |
101.68(B) |
| Last
Volume: |
7,700,656 |
Avg
Vol: |
8,211,804 |
| 52
Week Range: |
$43.78 - $83.04 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.9 |
| Insider 3/6 Months : 7.5 |
|
| Guru Rank Number : 19 |
| Guru Rank Value : 18.9 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,570 |
31,570 |
41,831 |
| Total Buy Value |
$0 |
$100,009 |
$2,101,009 |
$2,659,770 |
| Total People Bought |
0 |
1 |
2 |
4 |
| Total Buy Transactions |
0 |
1 |
2 |
7 |
| Total Shares Sold |
0 |
7,500 |
3,765,013 |
3,794,486 |
| Total Sell Value |
$0 |
$532,650 |
$254,726,551 |
$256,994,498 |
| Total People Sold |
0 |
1 |
3 |
4 |
| Total Sell Transactions |
0 |
1 |
5 |
6 |
| End Date |
2025-09-04 |
2025-06-03 |
2024-12-03 |
2023-12-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Clark James David |
SVP, Cont & Chief Acct Officer |
• • – |
2025-12-01 |
4 |
D |
$79.10 |
$17,402 |
D/D |
(220) |
24,401 |
|
- |
|
| Mandadi Tilak |
EVP, Chief Exp & Tech Officer |
• • – |
2025-11-30 |
4 |
D |
$80.36 |
$528,367 |
D/D |
(6,575) |
74,085 |
|
- |
|
| Capozzi Heidi B |
EVP and Chief People Officer |
• • – |
2025-11-30 |
4 |
D |
$80.36 |
$761,009 |
D/D |
(9,470) |
11,415 |
|
- |
|
| Farah Roger N |
Director |
• • – |
2025-11-30 |
4 |
D |
$80.36 |
$783,349 |
D/D |
(9,748) |
19,438 |
|
- |
|
| Sansone Guy P |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$125,618 |
D/D |
1,652 |
13,659 |
|
- |
|
| Aguirre Fernando |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$136,872 |
D/D |
1,800 |
40,950 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$44,940 |
D/D |
591 |
591 |
|
- |
|
| Brown C David II |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$134,971 |
D/D |
1,775 |
127,772 |
|
- |
|
| Shulman Douglas H. |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$125,618 |
D/D |
1,652 |
5,929 |
|
- |
|
| Norwalk Leslie V |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$125,618 |
D/D |
1,652 |
5,929 |
|
- |
|
| Kirby J Scott |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$125,618 |
D/D |
1,652 |
12,987 |
|
- |
|
| Balser Jeffrey R. |
Director |
• • – |
2025-11-20 |
4 |
A |
$76.04 |
$134,971 |
D/D |
1,775 |
13,659 |
|
- |
|
| Mandadi Tilak |
EVP, Chief Exp & Tech Officer |
• • – |
2025-08-31 |
4 |
D |
$73.15 |
$938,807 |
D/D |
(12,834) |
63,952 |
|
- |
|
| Shah Prem S |
EVP and Group President |
• • – |
2025-08-31 |
4 |
D |
$73.15 |
$511,684 |
D/D |
(6,995) |
60,632 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2025-08-20 |
4 |
S |
$71.02 |
$532,650 |
I/I |
(7,500) |
22,156 |
|
-13% |
|
| Sansone Guy P |
Director |
• • – |
2025-06-05 |
4 |
B |
$63.70 |
$100,009 |
D/D |
1,570 |
12,007 |
2.39 |
26% |
|
| Newman Brian |
EVP, Chief Financial Officer |
• • – |
2025-05-31 |
4 |
A |
$64.04 |
$1,399,978 |
D/D |
21,861 |
21,861 |
|
- |
|
| Compton-Phillips Amy |
EVP, Chief Medical Officer |
• • – |
2025-05-31 |
4 |
A |
$64.04 |
$3,399,948 |
D/D |
53,091 |
53,091 |
|
- |
|
| Compton-Phillips Amy |
EVP, Chief Medical OfficerOffi |
• – – |
2025-05-19 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
35 |
|
- |
|
| Shulman Douglas H. |
Director |
• • – |
2025-05-15 |
4 |
A |
$60.47 |
$125,596 |
D/D |
2,077 |
4,277 |
|
- |
|
| Sansone Guy P |
Director |
• • – |
2025-05-15 |
4 |
A |
$60.47 |
$125,596 |
D/D |
2,077 |
10,437 |
|
- |
|
| Norwalk Leslie V |
Director |
• • – |
2025-05-15 |
4 |
A |
$60.47 |
$125,596 |
D/D |
2,077 |
4,277 |
|
- |
|
| Kirby J Scott |
Director |
• • – |
2025-05-15 |
4 |
A |
$60.47 |
$167,441 |
D/D |
2,769 |
11,335 |
|
- |
|
| Brown C David II |
Director |
• • – |
2025-05-15 |
4 |
A |
$60.47 |
$134,969 |
D/D |
2,232 |
125,997 |
|
- |
|
| Finucane Anne A. |
Director |
• • – |
2025-05-15 |
4 |
A |
$60.47 |
$41,845 |
D/D |
692 |
692 |
|
- |
|
684 Records found
|
|
Page 1 of 28 |
|
|
1.48 (1.87%) 
